Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia - Tập 23 - Trang e41-e50 - 2023
David M. Foureau1, Barry A. Paul2, Fei Guo1, Edward H. Lipford3, Kateryna Fesenkova1, Elise Tjaden4, Kendra Drummond4, Manisha Bhutani2, Shebli Atrash2, Ami Ndiaye2, Cindy Varga2, Peter M. Voorhees2, Saad Z. Usmani5
1Immune Monitoring Core Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC
2Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
3Department of Hematologic Pathology, Atrium Health, Charlotte, NC
4Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC
5Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Clinical Lymphoma, Myeloma and Leukemia

Tập 23

e41-e50

Thông tin tác giả